Medical News

RSS

ACT's TEMPASURE cardiac ablation catheter receives CE Mark

Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, today announced that the company has received CE Mark (Conformité Européenne) clearance for its TEMPASURE™ cardiac ablation catheter. The TEMPASURE system is the world's first RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology.

8 Jun 2011

First Edition: June 8, 2011

Health insurer Blue Shield of California, under fire for a series of recent rate hikes and the pay of its chief executive, plans to cut this year's premiums by 2.5% for many of its 3.3 million policyholders as part of a new initiative to hold down costs (Helfand, 6/8).

8 Jun 2011

New journal on multiple sclerosis and related disorders

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, Multiple Sclerosis and Related Disorders with its first issue publication in January 2012.

8 Jun 2011

Study determines surfactant protein-D as 'a good predictor' of cardiovascular disease

A blood protein known as surfactant protein-D (SP-D), which is mainly synthesised in the lungs, has been described as "a good predictor" of cardiovascular disease following a large study in North America.

8 Jun 2011

ICU patients should wait a week before receiving intravenous feeding: New study

Patients in the intensive care unit who do not tolerate adequate nutrition from tube feeding should wait a week before receiving intravenous (IV) feeding because, compared with early IV feeding, it enhances recovery from critical illness.

8 Jun 2011

Grifols officially merges with Talecris Biotherapeutics

Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain, today announced that it has officially begun to merge its operations with Talecris Biotherapeutics in order to function as one company, following its acquisition of Talecris on June 1.

8 Jun 2011

Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, presented Phase 2 efficacy results for NeuVax in combination with trastuzumab at the American Society of Clinical Oncology (ASCO) annual meeting.

8 Jun 2011

Novation recognizes APP with NOVAPLUS Pharmacy Manufacturer of the Year

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., has been named NOVAPLUS Pharmacy Manufacturer of the Year by Novation, the industry's leading supply contracting company.

8 Jun 2011

Intercell, Merck terminate V710 Phase II/III trial against S. aureus infection

Merck, known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a detailed analysis of the data from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infection, the independent Data Monitoring Committee (DMC) has unanimously recommended termination of the study.

8 Jun 2011

Covidien files answer and counterclaims against Applied Medical for patent misuse, non-infringement

Covidien, a leading global provider of healthcare products, today announced that a subsidiary of the Company filed an answer and counterclaims against Applied Medical Resources Corporation for patent misuse, non-infringement and invalidity.

8 Jun 2011

Amedisys acquires Beacon Hospice

Amedisys, Inc., one of America's leading home health and hospice companies, today announced that on June 7, 2011, it closed the acquisition of Beacon Hospice, Inc.

8 Jun 2011

Rosa, Profil Institute partner to offer simulation technology for diabetes and obesity clinical trials

Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa's modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.

8 Jun 2011

Health-care professionals, researchers to attend Sixth World Conference on Breast Cancer

Today launches the sixth World Conference on Breast Cancer in Hamilton, Canada. The Conference is the only one of its kind to bring together breast cancer survivors, advocates, health-care professionals and researchers from developing and developed countries.

8 Jun 2011

Stop TB partnership releases 5 TB prevention steps

Ahead of the U.N. High Level Meeting on AIDS, the Stop TB Partnership released five guidelines aimed at preventing tuberculosis, which results in one in four AIDS-related deaths, the U.N. News Centre writes.

8 Jun 2011

IAS calls on leaders to ensure inclusion of HIV cure research into international AIDS agenda

As world leaders meet this week to review progress and chart the future course of the global AIDS response at the 2011 UN General Assembly High-Level Meeting on AIDS in New York, the International AIDS Society (IAS) calls on leaders to ensure the inclusion of HIV cure research and its global strategy into the international HIV agenda and in all discussions, political decisions and funding strategies.

8 Jun 2011

NYU Cancer Institute scientists present new research findings at ASCO 2011

Experts from The Cancer Institute, an NCI-designated cancer center, at NYU Langone Medical Center presented new research findings at the 47th American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago, IL.

8 Jun 2011

Global Fund's transparency is essential and saves lives

In the Huffington Post, Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, discusses the Global Fund's latest report on its investigation of its grants in Mali.

8 Jun 2011

New palonosetron-aprepitant trial data on chemotherapy induced nausea, vomiting presented at EHA

New data presented at the European Hematology Association (EHA) 2011 Annual Meeting in London show better control of nausea and vomiting with the combination palonosetron plus aprepitant when compared to granisetron in patients receiving multiday highly emetogenic conditioning chemotherapy regimens - Significantly higher the complete response during the acute, delayed and overall periods.

8 Jun 2011

GSK, Crucell to test second-generation malaria vaccine

GlaxoSmithKline and drug company Crucell, a division of Johnson & Johnson, will collaborate with the PATH Malaria Vaccine Initiative to test a second-generation malaria vaccine "within the next couple of months," Reuters reports.

8 Jun 2011

Ben Hogan Sports Medicine, StreamVenue partner to offer post-surgical management tool

StreamVenue Healthcare has partnered its "plug and play" products and services with Texas Health Ben Hogan Sports Medicine to teach, and to better manage post-surgical patient recovery.

8 Jun 2011

Medical News

ACT's TEMPASURE cardiac ablation catheter receives CE Mark

First Edition: June 8, 2011

New journal on multiple sclerosis and related disorders

Study determines surfactant protein-D as 'a good predictor' of cardiovascular disease

ICU patients should wait a week before receiving intravenous feeding: New study

Grifols officially merges with Talecris Biotherapeutics

Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO

Novation recognizes APP with NOVAPLUS Pharmacy Manufacturer of the Year

Intercell, Merck terminate V710 Phase II/III trial against S. aureus infection

Covidien files answer and counterclaims against Applied Medical for patent misuse, non-infringement

Amedisys acquires Beacon Hospice

Rosa, Profil Institute partner to offer simulation technology for diabetes and obesity clinical trials

Health-care professionals, researchers to attend Sixth World Conference on Breast Cancer

Stop TB partnership releases 5 TB prevention steps

IAS calls on leaders to ensure inclusion of HIV cure research into international AIDS agenda

NYU Cancer Institute scientists present new research findings at ASCO 2011

Global Fund's transparency is essential and saves lives

New palonosetron-aprepitant trial data on chemotherapy induced nausea, vomiting presented at EHA

GSK, Crucell to test second-generation malaria vaccine

Ben Hogan Sports Medicine, StreamVenue partner to offer post-surgical management tool

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News